Global Inactivated Hepatitis A Vaccine Market Growth 2026-2032
The global Inactivated Hepatitis A Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Inactivated Hepatitis A Vaccine is a type of vaccine designed to protect against the Hepatitis A virus. Hepatitis A is a viral infection that primarily affects the liver and is usually spread through contaminated food or water. The inactivated Hepatitis A vaccine is a preventive measure that helps the immune system recognize and fight the virus.
United States market for Inactivated Hepatitis A Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Inactivated Hepatitis A Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Inactivated Hepatitis A Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Inactivated Hepatitis A Vaccine players cover Hualan Vaccine, SINOVAC, GSK, Merck, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Inactivated Hepatitis A Vaccine Industry Forecast? looks at past sales and reviews total world Inactivated Hepatitis A Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Inactivated Hepatitis A Vaccine sales for 2026 through 2032. With Inactivated Hepatitis A Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inactivated Hepatitis A Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Inactivated Hepatitis A Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inactivated Hepatitis A Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Inactivated Hepatitis A Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inactivated Hepatitis A Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inactivated Hepatitis A Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Inactivated Hepatitis A Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Inactivated Hepatitis A Vaccine is a type of vaccine designed to protect against the Hepatitis A virus. Hepatitis A is a viral infection that primarily affects the liver and is usually spread through contaminated food or water. The inactivated Hepatitis A vaccine is a preventive measure that helps the immune system recognize and fight the virus.
United States market for Inactivated Hepatitis A Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Inactivated Hepatitis A Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Inactivated Hepatitis A Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Inactivated Hepatitis A Vaccine players cover Hualan Vaccine, SINOVAC, GSK, Merck, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Inactivated Hepatitis A Vaccine Industry Forecast? looks at past sales and reviews total world Inactivated Hepatitis A Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Inactivated Hepatitis A Vaccine sales for 2026 through 2032. With Inactivated Hepatitis A Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inactivated Hepatitis A Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Inactivated Hepatitis A Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inactivated Hepatitis A Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Inactivated Hepatitis A Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inactivated Hepatitis A Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inactivated Hepatitis A Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Inactivated Hepatitis A Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 1.0ml
- 0.5ml
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hualan Vaccine
- SINOVAC
- GSK
- Merck
- Sanofi
- KM Biologics
- IMBCAMS
- AIM Vaccine
- AIM Action
- What is the 10-year outlook for the global Inactivated Hepatitis A Vaccine market?
- What factors are driving Inactivated Hepatitis A Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Inactivated Hepatitis A Vaccine market opportunities vary by end market size?
- How does Inactivated Hepatitis A Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Inactivated Hepatitis A Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Inactivated Hepatitis A Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Inactivated Hepatitis A Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Inactivated Hepatitis A Vaccine Segment by Type
2.2.1 1.0ml
2.2.2 0.5ml
2.2.3 Inactivated Hepatitis A Vaccine Sales by Type
2.2.3.1 Global Inactivated Hepatitis A Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Inactivated Hepatitis A Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Inactivated Hepatitis A Vaccine Sale Price by Type (2021-2026)
2.3 Inactivated Hepatitis A Vaccine Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Inactivated Hepatitis A Vaccine Sales by Application
2.3.3.1 Global Inactivated Hepatitis A Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Inactivated Hepatitis A Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Inactivated Hepatitis A Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Inactivated Hepatitis A Vaccine Breakdown Data by Company
3.1.1 Global Inactivated Hepatitis A Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Inactivated Hepatitis A Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Inactivated Hepatitis A Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Inactivated Hepatitis A Vaccine Revenue by Company (2021-2026)
3.2.2 Global Inactivated Hepatitis A Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Inactivated Hepatitis A Vaccine Sale Price by Company
3.4 Key Manufacturers Inactivated Hepatitis A Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inactivated Hepatitis A Vaccine Product Location Distribution
3.4.2 Players Inactivated Hepatitis A Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INACTIVATED HEPATITIS A VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Inactivated Hepatitis A Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Inactivated Hepatitis A Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Inactivated Hepatitis A Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Inactivated Hepatitis A Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Inactivated Hepatitis A Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Inactivated Hepatitis A Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Inactivated Hepatitis A Vaccine Sales Growth
4.4 APAC Inactivated Hepatitis A Vaccine Sales Growth
4.5 Europe Inactivated Hepatitis A Vaccine Sales Growth
4.6 Middle East & Africa Inactivated Hepatitis A Vaccine Sales Growth
5 AMERICAS
5.1 Americas Inactivated Hepatitis A Vaccine Sales by Country
5.1.1 Americas Inactivated Hepatitis A Vaccine Sales by Country (2021-2026)
5.1.2 Americas Inactivated Hepatitis A Vaccine Revenue by Country (2021-2026)
5.2 Americas Inactivated Hepatitis A Vaccine Sales by Type (2021-2026)
5.3 Americas Inactivated Hepatitis A Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inactivated Hepatitis A Vaccine Sales by Region
6.1.1 APAC Inactivated Hepatitis A Vaccine Sales by Region (2021-2026)
6.1.2 APAC Inactivated Hepatitis A Vaccine Revenue by Region (2021-2026)
6.2 APAC Inactivated Hepatitis A Vaccine Sales by Type (2021-2026)
6.3 APAC Inactivated Hepatitis A Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Inactivated Hepatitis A Vaccine by Country
7.1.1 Europe Inactivated Hepatitis A Vaccine Sales by Country (2021-2026)
7.1.2 Europe Inactivated Hepatitis A Vaccine Revenue by Country (2021-2026)
7.2 Europe Inactivated Hepatitis A Vaccine Sales by Type (2021-2026)
7.3 Europe Inactivated Hepatitis A Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Inactivated Hepatitis A Vaccine by Country
8.1.1 Middle East & Africa Inactivated Hepatitis A Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Inactivated Hepatitis A Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Inactivated Hepatitis A Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Inactivated Hepatitis A Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inactivated Hepatitis A Vaccine
10.3 Manufacturing Process Analysis of Inactivated Hepatitis A Vaccine
10.4 Industry Chain Structure of Inactivated Hepatitis A Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inactivated Hepatitis A Vaccine Distributors
11.3 Inactivated Hepatitis A Vaccine Customer
12 WORLD FORECAST REVIEW FOR INACTIVATED HEPATITIS A VACCINE BY GEOGRAPHIC REGION
12.1 Global Inactivated Hepatitis A Vaccine Market Size Forecast by Region
12.1.1 Global Inactivated Hepatitis A Vaccine Forecast by Region (2027-2032)
12.1.2 Global Inactivated Hepatitis A Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Inactivated Hepatitis A Vaccine Forecast by Type (2027-2032)
12.7 Global Inactivated Hepatitis A Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Hualan Vaccine
13.1.1 Hualan Vaccine Company Information
13.1.2 Hualan Vaccine Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.1.3 Hualan Vaccine Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Hualan Vaccine Main Business Overview
13.1.5 Hualan Vaccine Latest Developments
13.2 SINOVAC
13.2.1 SINOVAC Company Information
13.2.2 SINOVAC Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.2.3 SINOVAC Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 SINOVAC Main Business Overview
13.2.5 SINOVAC Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.3.3 GSK Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.4.3 Merck Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.5.3 Sanofi Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 KM Biologics
13.6.1 KM Biologics Company Information
13.6.2 KM Biologics Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.6.3 KM Biologics Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 KM Biologics Main Business Overview
13.6.5 KM Biologics Latest Developments
13.7 IMBCAMS
13.7.1 IMBCAMS Company Information
13.7.2 IMBCAMS Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.7.3 IMBCAMS Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 IMBCAMS Main Business Overview
13.7.5 IMBCAMS Latest Developments
13.8 AIM Vaccine
13.8.1 AIM Vaccine Company Information
13.8.2 AIM Vaccine Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.8.3 AIM Vaccine Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 AIM Vaccine Main Business Overview
13.8.5 AIM Vaccine Latest Developments
13.9 AIM Action
13.9.1 AIM Action Company Information
13.9.2 AIM Action Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.9.3 AIM Action Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 AIM Action Main Business Overview
13.9.5 AIM Action Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Inactivated Hepatitis A Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Inactivated Hepatitis A Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Inactivated Hepatitis A Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Inactivated Hepatitis A Vaccine Segment by Type
2.2.1 1.0ml
2.2.2 0.5ml
2.2.3 Inactivated Hepatitis A Vaccine Sales by Type
2.2.3.1 Global Inactivated Hepatitis A Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Inactivated Hepatitis A Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Inactivated Hepatitis A Vaccine Sale Price by Type (2021-2026)
2.3 Inactivated Hepatitis A Vaccine Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Inactivated Hepatitis A Vaccine Sales by Application
2.3.3.1 Global Inactivated Hepatitis A Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Inactivated Hepatitis A Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Inactivated Hepatitis A Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Inactivated Hepatitis A Vaccine Breakdown Data by Company
3.1.1 Global Inactivated Hepatitis A Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Inactivated Hepatitis A Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Inactivated Hepatitis A Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Inactivated Hepatitis A Vaccine Revenue by Company (2021-2026)
3.2.2 Global Inactivated Hepatitis A Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Inactivated Hepatitis A Vaccine Sale Price by Company
3.4 Key Manufacturers Inactivated Hepatitis A Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inactivated Hepatitis A Vaccine Product Location Distribution
3.4.2 Players Inactivated Hepatitis A Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INACTIVATED HEPATITIS A VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Inactivated Hepatitis A Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Inactivated Hepatitis A Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Inactivated Hepatitis A Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Inactivated Hepatitis A Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Inactivated Hepatitis A Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Inactivated Hepatitis A Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Inactivated Hepatitis A Vaccine Sales Growth
4.4 APAC Inactivated Hepatitis A Vaccine Sales Growth
4.5 Europe Inactivated Hepatitis A Vaccine Sales Growth
4.6 Middle East & Africa Inactivated Hepatitis A Vaccine Sales Growth
5 AMERICAS
5.1 Americas Inactivated Hepatitis A Vaccine Sales by Country
5.1.1 Americas Inactivated Hepatitis A Vaccine Sales by Country (2021-2026)
5.1.2 Americas Inactivated Hepatitis A Vaccine Revenue by Country (2021-2026)
5.2 Americas Inactivated Hepatitis A Vaccine Sales by Type (2021-2026)
5.3 Americas Inactivated Hepatitis A Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inactivated Hepatitis A Vaccine Sales by Region
6.1.1 APAC Inactivated Hepatitis A Vaccine Sales by Region (2021-2026)
6.1.2 APAC Inactivated Hepatitis A Vaccine Revenue by Region (2021-2026)
6.2 APAC Inactivated Hepatitis A Vaccine Sales by Type (2021-2026)
6.3 APAC Inactivated Hepatitis A Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Inactivated Hepatitis A Vaccine by Country
7.1.1 Europe Inactivated Hepatitis A Vaccine Sales by Country (2021-2026)
7.1.2 Europe Inactivated Hepatitis A Vaccine Revenue by Country (2021-2026)
7.2 Europe Inactivated Hepatitis A Vaccine Sales by Type (2021-2026)
7.3 Europe Inactivated Hepatitis A Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Inactivated Hepatitis A Vaccine by Country
8.1.1 Middle East & Africa Inactivated Hepatitis A Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Inactivated Hepatitis A Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Inactivated Hepatitis A Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Inactivated Hepatitis A Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inactivated Hepatitis A Vaccine
10.3 Manufacturing Process Analysis of Inactivated Hepatitis A Vaccine
10.4 Industry Chain Structure of Inactivated Hepatitis A Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inactivated Hepatitis A Vaccine Distributors
11.3 Inactivated Hepatitis A Vaccine Customer
12 WORLD FORECAST REVIEW FOR INACTIVATED HEPATITIS A VACCINE BY GEOGRAPHIC REGION
12.1 Global Inactivated Hepatitis A Vaccine Market Size Forecast by Region
12.1.1 Global Inactivated Hepatitis A Vaccine Forecast by Region (2027-2032)
12.1.2 Global Inactivated Hepatitis A Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Inactivated Hepatitis A Vaccine Forecast by Type (2027-2032)
12.7 Global Inactivated Hepatitis A Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Hualan Vaccine
13.1.1 Hualan Vaccine Company Information
13.1.2 Hualan Vaccine Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.1.3 Hualan Vaccine Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Hualan Vaccine Main Business Overview
13.1.5 Hualan Vaccine Latest Developments
13.2 SINOVAC
13.2.1 SINOVAC Company Information
13.2.2 SINOVAC Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.2.3 SINOVAC Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 SINOVAC Main Business Overview
13.2.5 SINOVAC Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.3.3 GSK Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.4.3 Merck Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.5.3 Sanofi Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 KM Biologics
13.6.1 KM Biologics Company Information
13.6.2 KM Biologics Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.6.3 KM Biologics Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 KM Biologics Main Business Overview
13.6.5 KM Biologics Latest Developments
13.7 IMBCAMS
13.7.1 IMBCAMS Company Information
13.7.2 IMBCAMS Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.7.3 IMBCAMS Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 IMBCAMS Main Business Overview
13.7.5 IMBCAMS Latest Developments
13.8 AIM Vaccine
13.8.1 AIM Vaccine Company Information
13.8.2 AIM Vaccine Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.8.3 AIM Vaccine Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 AIM Vaccine Main Business Overview
13.8.5 AIM Vaccine Latest Developments
13.9 AIM Action
13.9.1 AIM Action Company Information
13.9.2 AIM Action Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
13.9.3 AIM Action Inactivated Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 AIM Action Main Business Overview
13.9.5 AIM Action Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Inactivated Hepatitis A Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Inactivated Hepatitis A Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1.0ml
Table 4. Major Players of 0.5ml
Table 5. Global Inactivated Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Inactivated Hepatitis A Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Inactivated Hepatitis A Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Inactivated Hepatitis A Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Inactivated Hepatitis A Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Inactivated Hepatitis A Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Inactivated Hepatitis A Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Inactivated Hepatitis A Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Inactivated Hepatitis A Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Inactivated Hepatitis A Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Inactivated Hepatitis A Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Inactivated Hepatitis A Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Inactivated Hepatitis A Vaccine Producing Area Distribution and Sales Area
Table 21. Players Inactivated Hepatitis A Vaccine Products Offered
Table 22. Inactivated Hepatitis A Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Inactivated Hepatitis A Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Inactivated Hepatitis A Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Inactivated Hepatitis A Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Inactivated Hepatitis A Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Inactivated Hepatitis A Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Inactivated Hepatitis A Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Inactivated Hepatitis A Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Inactivated Hepatitis A Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Inactivated Hepatitis A Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Inactivated Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Inactivated Hepatitis A Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Inactivated Hepatitis A Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Inactivated Hepatitis A Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Inactivated Hepatitis A Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Inactivated Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Inactivated Hepatitis A Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Inactivated Hepatitis A Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Inactivated Hepatitis A Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Inactivated Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Inactivated Hepatitis A Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Inactivated Hepatitis A Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Inactivated Hepatitis A Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Inactivated Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Inactivated Hepatitis A Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Inactivated Hepatitis A Vaccine
Table 52. Key Market Challenges & Risks of Inactivated Hepatitis A Vaccine
Table 53. Key Industry Trends of Inactivated Hepatitis A Vaccine
Table 54. Inactivated Hepatitis A Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Inactivated Hepatitis A Vaccine Distributors List
Table 57. Inactivated Hepatitis A Vaccine Customer List
Table 58. Global Inactivated Hepatitis A Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Inactivated Hepatitis A Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Inactivated Hepatitis A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Inactivated Hepatitis A Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Inactivated Hepatitis A Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Inactivated Hepatitis A Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Inactivated Hepatitis A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Inactivated Hepatitis A Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Inactivated Hepatitis A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Inactivated Hepatitis A Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Inactivated Hepatitis A Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Inactivated Hepatitis A Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Inactivated Hepatitis A Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Inactivated Hepatitis A Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Hualan Vaccine Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Hualan Vaccine Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 74. Hualan Vaccine Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Hualan Vaccine Main Business
Table 76. Hualan Vaccine Latest Developments
Table 77. SINOVAC Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. SINOVAC Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 79. SINOVAC Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. SINOVAC Main Business
Table 81. SINOVAC Latest Developments
Table 82. GSK Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. GSK Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 84. GSK Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. GSK Main Business
Table 86. GSK Latest Developments
Table 87. Merck Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 89. Merck Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Merck Main Business
Table 91. Merck Latest Developments
Table 92. Sanofi Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 94. Sanofi Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. KM Biologics Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. KM Biologics Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 99. KM Biologics Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. KM Biologics Main Business
Table 101. KM Biologics Latest Developments
Table 102. IMBCAMS Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. IMBCAMS Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 104. IMBCAMS Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. IMBCAMS Main Business
Table 106. IMBCAMS Latest Developments
Table 107. AIM Vaccine Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. AIM Vaccine Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 109. AIM Vaccine Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. AIM Vaccine Main Business
Table 111. AIM Vaccine Latest Developments
Table 112. AIM Action Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. AIM Action Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 114. AIM Action Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. AIM Action Main Business
Table 116. AIM Action Latest Developments
Table 1. Inactivated Hepatitis A Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Inactivated Hepatitis A Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1.0ml
Table 4. Major Players of 0.5ml
Table 5. Global Inactivated Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Inactivated Hepatitis A Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Inactivated Hepatitis A Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Inactivated Hepatitis A Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Inactivated Hepatitis A Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Inactivated Hepatitis A Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Inactivated Hepatitis A Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Inactivated Hepatitis A Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Inactivated Hepatitis A Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Inactivated Hepatitis A Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Inactivated Hepatitis A Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Inactivated Hepatitis A Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Inactivated Hepatitis A Vaccine Producing Area Distribution and Sales Area
Table 21. Players Inactivated Hepatitis A Vaccine Products Offered
Table 22. Inactivated Hepatitis A Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Inactivated Hepatitis A Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Inactivated Hepatitis A Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Inactivated Hepatitis A Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Inactivated Hepatitis A Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Inactivated Hepatitis A Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Inactivated Hepatitis A Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Inactivated Hepatitis A Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Inactivated Hepatitis A Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Inactivated Hepatitis A Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Inactivated Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Inactivated Hepatitis A Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Inactivated Hepatitis A Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Inactivated Hepatitis A Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Inactivated Hepatitis A Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Inactivated Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Inactivated Hepatitis A Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Inactivated Hepatitis A Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Inactivated Hepatitis A Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Inactivated Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Inactivated Hepatitis A Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Inactivated Hepatitis A Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Inactivated Hepatitis A Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Inactivated Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Inactivated Hepatitis A Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Inactivated Hepatitis A Vaccine
Table 52. Key Market Challenges & Risks of Inactivated Hepatitis A Vaccine
Table 53. Key Industry Trends of Inactivated Hepatitis A Vaccine
Table 54. Inactivated Hepatitis A Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Inactivated Hepatitis A Vaccine Distributors List
Table 57. Inactivated Hepatitis A Vaccine Customer List
Table 58. Global Inactivated Hepatitis A Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Inactivated Hepatitis A Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Inactivated Hepatitis A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Inactivated Hepatitis A Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Inactivated Hepatitis A Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Inactivated Hepatitis A Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Inactivated Hepatitis A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Inactivated Hepatitis A Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Inactivated Hepatitis A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Inactivated Hepatitis A Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Inactivated Hepatitis A Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Inactivated Hepatitis A Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Inactivated Hepatitis A Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Inactivated Hepatitis A Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Hualan Vaccine Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Hualan Vaccine Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 74. Hualan Vaccine Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Hualan Vaccine Main Business
Table 76. Hualan Vaccine Latest Developments
Table 77. SINOVAC Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. SINOVAC Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 79. SINOVAC Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. SINOVAC Main Business
Table 81. SINOVAC Latest Developments
Table 82. GSK Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. GSK Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 84. GSK Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. GSK Main Business
Table 86. GSK Latest Developments
Table 87. Merck Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 89. Merck Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Merck Main Business
Table 91. Merck Latest Developments
Table 92. Sanofi Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 94. Sanofi Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. KM Biologics Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. KM Biologics Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 99. KM Biologics Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. KM Biologics Main Business
Table 101. KM Biologics Latest Developments
Table 102. IMBCAMS Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. IMBCAMS Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 104. IMBCAMS Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. IMBCAMS Main Business
Table 106. IMBCAMS Latest Developments
Table 107. AIM Vaccine Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. AIM Vaccine Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 109. AIM Vaccine Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. AIM Vaccine Main Business
Table 111. AIM Vaccine Latest Developments
Table 112. AIM Action Basic Information, Inactivated Hepatitis A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. AIM Action Inactivated Hepatitis A Vaccine Product Portfolios and Specifications
Table 114. AIM Action Inactivated Hepatitis A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. AIM Action Main Business
Table 116. AIM Action Latest Developments
LIST OF FIGURES
Figure 1. Picture of Inactivated Hepatitis A Vaccine
Figure 2. Inactivated Hepatitis A Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inactivated Hepatitis A Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Inactivated Hepatitis A Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Inactivated Hepatitis A Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Inactivated Hepatitis A Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Inactivated Hepatitis A Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1.0ml
Figure 12. Product Picture of 0.5ml
Figure 13. Global Inactivated Hepatitis A Vaccine Sales Market Share by Type in 2026
Figure 14. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Inactivated Hepatitis A Vaccine Consumed in Hospital
Figure 16. Global Inactivated Hepatitis A Vaccine Market: Hospital (2021-2026) & (K Units)
Figure 17. Inactivated Hepatitis A Vaccine Consumed in Clinic
Figure 18. Global Inactivated Hepatitis A Vaccine Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Inactivated Hepatitis A Vaccine Sale Market Share by Application (2025)
Figure 20. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Application in 2026
Figure 21. Inactivated Hepatitis A Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Inactivated Hepatitis A Vaccine Sales Market Share by Company in 2026
Figure 23. Inactivated Hepatitis A Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Inactivated Hepatitis A Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Inactivated Hepatitis A Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Inactivated Hepatitis A Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Inactivated Hepatitis A Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Inactivated Hepatitis A Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Inactivated Hepatitis A Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Inactivated Hepatitis A Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Inactivated Hepatitis A Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Inactivated Hepatitis A Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Inactivated Hepatitis A Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Inactivated Hepatitis A Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Inactivated Hepatitis A Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Inactivated Hepatitis A Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Inactivated Hepatitis A Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Inactivated Hepatitis A Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Inactivated Hepatitis A Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Inactivated Hepatitis A Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Inactivated Hepatitis A Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Inactivated Hepatitis A Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Inactivated Hepatitis A Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Inactivated Hepatitis A Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Inactivated Hepatitis A Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Inactivated Hepatitis A Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Inactivated Hepatitis A Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Inactivated Hepatitis A Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Inactivated Hepatitis A Vaccine
Figure 73. Industry Chain Structure of Inactivated Hepatitis A Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Inactivated Hepatitis A Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Inactivated Hepatitis A Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Inactivated Hepatitis A Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Inactivated Hepatitis A Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Inactivated Hepatitis A Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Inactivated Hepatitis A Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Inactivated Hepatitis A Vaccine
Figure 2. Inactivated Hepatitis A Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inactivated Hepatitis A Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Inactivated Hepatitis A Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Inactivated Hepatitis A Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Inactivated Hepatitis A Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Inactivated Hepatitis A Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1.0ml
Figure 12. Product Picture of 0.5ml
Figure 13. Global Inactivated Hepatitis A Vaccine Sales Market Share by Type in 2026
Figure 14. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Inactivated Hepatitis A Vaccine Consumed in Hospital
Figure 16. Global Inactivated Hepatitis A Vaccine Market: Hospital (2021-2026) & (K Units)
Figure 17. Inactivated Hepatitis A Vaccine Consumed in Clinic
Figure 18. Global Inactivated Hepatitis A Vaccine Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Inactivated Hepatitis A Vaccine Sale Market Share by Application (2025)
Figure 20. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Application in 2026
Figure 21. Inactivated Hepatitis A Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Inactivated Hepatitis A Vaccine Sales Market Share by Company in 2026
Figure 23. Inactivated Hepatitis A Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Inactivated Hepatitis A Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Inactivated Hepatitis A Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Inactivated Hepatitis A Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Inactivated Hepatitis A Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Inactivated Hepatitis A Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Inactivated Hepatitis A Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Inactivated Hepatitis A Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Inactivated Hepatitis A Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Inactivated Hepatitis A Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Inactivated Hepatitis A Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Inactivated Hepatitis A Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Inactivated Hepatitis A Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Inactivated Hepatitis A Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Inactivated Hepatitis A Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Inactivated Hepatitis A Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Inactivated Hepatitis A Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Inactivated Hepatitis A Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Inactivated Hepatitis A Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Inactivated Hepatitis A Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Inactivated Hepatitis A Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Inactivated Hepatitis A Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Inactivated Hepatitis A Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Inactivated Hepatitis A Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Inactivated Hepatitis A Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Inactivated Hepatitis A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Inactivated Hepatitis A Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Inactivated Hepatitis A Vaccine
Figure 73. Industry Chain Structure of Inactivated Hepatitis A Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Inactivated Hepatitis A Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Inactivated Hepatitis A Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Inactivated Hepatitis A Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Inactivated Hepatitis A Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Inactivated Hepatitis A Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Inactivated Hepatitis A Vaccine Revenue Market Share Forecast by Application (2027-2032)
